<!DOCTYPE html><!--  Last Published: Sun May 29 2022 13:25:18 GMT+0000 (Coordinated Universal Time)  -->
<html data-wf-page="610e70c5e987d875d9c8563d" data-wf-site="610e70c5e987d8bd9fc8563b" lang="en">
<head>
  <meta charset="utf-8">
  <title>HCP Engagement Website by Tech for Bio</title>
  <meta content="The demo site offers multiple engagement possibilities for HCPs. It also gathers several metrics to measure the audience behavior." name="description">
  <meta content="HCP Engagement Website by Tech for Bio" property="og:title">
  <meta content="The demo site offers multiple engagement possibilities for HCPs. It also gathers several metrics to measure the audience behavior." property="og:description">
  <meta content="https://uploads-ssl.webflow.com/610e70c5e987d8bd9fc8563b/61b0fbb70f13695f42b26bd1_Screenshot%202021-12-08%20at%2019.36.02(1).png" property="og:image">
  <meta content="HCP Engagement Website by Tech for Bio" property="twitter:title">
  <meta content="The demo site offers multiple engagement possibilities for HCPs. It also gathers several metrics to measure the audience behavior." property="twitter:description">
  <meta content="https://uploads-ssl.webflow.com/610e70c5e987d8bd9fc8563b/61b0fbb70f13695f42b26bd1_Screenshot%202021-12-08%20at%2019.36.02(1).png" property="twitter:image">
  <meta property="og:type" content="website">
  <meta content="summary_large_image" name="twitter:card">
  <meta content="width=device-width, initial-scale=1" name="viewport">
  <link href="css/normalize.css" rel="stylesheet" type="text/css">
  <link href="css/components.css" rel="stylesheet" type="text/css">
  <link href="css/ace-demo-io.css" rel="stylesheet" type="text/css">
  <!-- [if lt IE 9]><script src="https://cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv.min.js" type="text/javascript"></script><![endif] -->
  <script type="text/javascript">!function(o,c){var n=c.documentElement,t=" w-mod-";n.className+=t+"js",("ontouchstart"in o||o.DocumentTouch&&c instanceof DocumentTouch)&&(n.className+=t+"touch")}(window,document);</script>
  <link href="images/favicon.png" rel="shortcut icon" type="image/x-icon">
  <link href="images/webclip.png" rel="apple-touch-icon">
  <script async="" src="https://www.googletagmanager.com/gtag/js?id=G-28QVTES40L"></script>
  <script type="text/javascript">window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments);}gtag('js', new Date());gtag('config', 'G-28QVTES40L', {'anonymize_ip': true});</script>
  <script defer="" src="https://unpkg.com/@alpinejs/intersect@3.x.x/dist/cdn.min.js"></script>
  <script defer="" src="https://cdn.jsdelivr.net/npm/@loomchild/webflow-alpinejs@2/dist/index.js"></script>
  <!--  Matomo  -->
  <script>
  var _paq = window._paq = window._paq || [];
  _paq.push(['disableCookies']);
  _paq.push(['trackPageView']);
  _paq.push(['enableLinkTracking']);
  (function() {
    var u="https://untitledfactory.matomo.cloud/";
    _paq.push(['setTrackerUrl', u+'matomo.php']);
    _paq.push(['setSiteId', '2']);
    var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
    g.async=true; g.src='//cdn.matomo.cloud/untitledfactory.matomo.cloud/matomo.js'; s.parentNode.insertBefore(g,s);
  })();
</script>
  <!--  End Matomo Code  -->
</head>
<body>
  <div class="custom-style w-embed">
    <link href="https://cdn.jsdelivr.net/npm/@loomchild/webflow-alpinejs@2/dist/style.css" rel="stylesheet">
    <style>
body {
  overscroll-behavior-y: contain;
}
a {
  color: inherit;
}
.sprite-wrapper {
  overflow-x: clip;  /* Unfortunately no Safari support */
  overflow-y: visible;
}
.menu-list {
  backdrop-filter: blur(3px);
}
.arrow.top .arrow-content {
  top: 0;
  align-items: flex-end;
}
.arrow.bottom .arrow-content {
  bottom: 0;
}
.arrow.left .arrow-content {
  left: 0;
  justify-content: flex-start;
  margin-left: -30px;
}
.arrow.right .arrow-content {
  right: 0;
  justify-content: flex-end;
  margin-right: -30px;
}
@media screen and (max-width: 478px) {
  .arrow.left .arrow-content {
    margin-left: -15px;
  }
  .arrow.right .arrow-content {
    margin-right: -15px;
  }
}
.arrow.top.right img {
  transform: scaleX(-1);
  order: 100;
}
.arrow.bottom.left img {
  transform: scaleY(-1);
}
.arrow.bottom.right img {
  transform: scaleX(-1) scaleY(-1);
  order: 100;
}
.arrow.small img.small {
  display: block;
}
.arrow.small img:not(.small) {
  display: none;
}
.arrow.small.left .arrow-content {
  margin-left: -20px !important;
}
.arrow.small.right .arrow-content {
  margin-right: -20px !important;
}
</style>
  </div>
  <div data-hover="false" data-delay="0" class="menu-dropdown w-dropdown">
    <div class="menu w-dropdown-toggle"><img src="images/squarekebeb.png" loading="lazy" width="40" alt="Menu"></div>
    <nav class="menu-list w-dropdown-list">
      <a href="#introduction" class="menu-link w-dropdown-link">Introduction</a>
      <a href="#status" class="menu-link w-dropdown-link">HER2 status</a>
      <a href="#therapy" class="menu-link w-dropdown-link">Anti-HER2 therapy</a>
      <a href="#history" class="menu-link w-dropdown-link">History of trastuzumab</a>
      <a href="#patients" class="menu-link w-dropdown-link">HER2-negative patients</a>
      <a href="#adc-therapy" class="menu-link w-dropdown-link">Anti-HER2 ADC therapy</a>
      <a href="#moa" class="menu-link w-dropdown-link">T-DXd mechanism of action</a>
      <a href="#poll" class="menu-link w-dropdown-link">Share your opinion!</a>
      <a href="#more-information" class="menu-link w-dropdown-link">More information</a>
    </nav>
  </div>
  <div class="background-gradient"></div>
  <div class="background-image"></div>
  <header id="introduction" class="section wf-section">
    <div class="container w-container">
      <div class="intro-section-wrapper">
        <h1 class="title">Advances in Anti-HER2 Antibody Treatment<br>for Breast Cancer</h1>
        <div class="subtitle-wrapper">
          <div class="subtitle">HER2 stands for Human Epidermal Growth Factor Receptor 2. It controls cell growth and its increased presence is found in about 20% of breast cancers. Over-expression of HER2 is associated with aggressive disease and higher mortality.</div>
        </div>
      </div>
      <div class="intro-section-image-wrapper">
        <div class="image-wrapper"><img src="images/Visuals-for-the-IO-mockup_Cell-and-tumor2x.png" loading="eager" height="600" width="600" srcset="images/Visuals-for-the-IO-mockup_Cell-and-tumor2x-p-500.png 500w, images/Visuals-for-the-IO-mockup_Cell-and-tumor2x.png 1200w" sizes="(max-width: 479px) 87vw, (max-width: 767px) 80vw, 600px" alt="Introduction - HER2+ cell" class="deck-image">
          <div x-data="arrow({ delay: 100 })" class="arrow top left intro">
            <div x-cloak="1" uncloak="1" class="arrow-wrapper">
              <div x-bind="trigger" class="arrow-trigger"></div>
              <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                <div class="arrow-label">HER2 is a membrane<br>-bound receptor</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </header>
  <div id="status" class="section wf-section">
    <div class="container w-container">
      <div class="section-wrapper">
        <div class="section-content-wrapper">
          <h2 class="heading">HER2 status</h2>
          <p>Patients showing higher than normal levels of HER2 are classified as HER2-positive (HER2+), while patients with normal levels are considered HER2-negative (HER2-). HER2 is an independent predictor of prognosis in women with breast cancer.</p>
        </div>
      </div>
    </div>
  </div>
  <div class="section wf-section">
    <div class="gradient-background-wrapper">
      <div class="gradient-highlight">
        <div class="gradient-highlight-half top"></div>
        <div class="gradient-highlight-half bottom"></div>
      </div>
    </div>
    <div class="sprite-wrapper no-clip">
      <div class="container wide sprite-container w-container">
        <div class="survival-poll-image"></div>
        <div class="survival-poll-source-label">Data from the National Cancer Institute</div>
      </div>
    </div>
    <div class="container wide w-container">
      <div x-data="survivalPoll" class="survival-poll">
        <div class="survival-poll-answer">
          <div x-show="value == null" x-bind="answer" class="survival-poll-answer-wrapper">
            <div class="survival-poll-answer-title">?</div>
          </div>
          <div x-cloak="1" x-show="value == 1" x-bind="answer" class="survival-poll-answer-wrapper">
            <div class="survival-poll-answer-title">90%</div>
            <div class="survival-poll-answer-subtitle">4-year survival rate</div>
          </div>
          <div x-cloak="1" x-show="value == 2" x-bind="answer" class="survival-poll-answer-wrapper">
            <div class="survival-poll-answer-title">83%</div>
            <div class="survival-poll-answer-subtitle">4-year survival rate</div>
          </div>
          <div x-cloak="1" x-show="value == 3" x-bind="answer" class="survival-poll-answer-wrapper">
            <div class="survival-poll-answer-title">93%</div>
            <div class="survival-poll-answer-subtitle">4-year survival rate</div>
          </div>
          <div x-cloak="1" x-show="value == 4" x-bind="answer" class="survival-poll-answer-wrapper">
            <div class="survival-poll-answer-title">77%</div>
            <div class="survival-poll-answer-subtitle">4-year survival rate</div>
          </div>
        </div>
        <div class="survival-poll-question">
          <h3 class="subheading">Evaluate survival rates based on patient’s HER2 and hormone receptor (HR) status</h3>
          <div class="w-form">
            <form id="email-form" name="email-form" data-name="Email Form" method="get" class="survival-poll-form"><label x-model="value" class="radio-button-field w-radio">
                <div class="w-form-formradioinput w-form-formradioinput--inputType-custom radio-button w-radio-input"></div><input type="radio" data-name="Survival Poll" id="node-2" name="Survival-Poll" value="1" style="opacity:0;position:absolute;z-index:-1"><span for="node-2" class="radio-button-label w-form-label">HER2+<br>HR+</span>
              </label><label x-model="value" class="radio-button-field w-radio">
                <div class="w-form-formradioinput w-form-formradioinput--inputType-custom radio-button w-radio-input"></div><input type="radio" data-name="Survival Poll" id="node-3" name="Survival-Poll" value="2" style="opacity:0;position:absolute;z-index:-1"><span for="node-3" class="radio-button-label w-form-label">HER2+<br>HR-</span>
              </label><label x-model="value" class="radio-button-field w-radio">
                <div class="w-form-formradioinput w-form-formradioinput--inputType-custom radio-button w-radio-input"></div><input type="radio" data-name="Survival Poll" id="node-4" name="Survival-Poll" value="3" style="opacity:0;position:absolute;z-index:-1"><span for="node-4" class="radio-button-label w-form-label">HER2-<br>HR+</span>
              </label><label x-model="value" class="radio-button-field w-radio">
                <div class="w-form-formradioinput w-form-formradioinput--inputType-custom radio-button w-radio-input"></div><input type="radio" data-name="Survival Poll" id="node-5" name="Survival-Poll" value="4" style="opacity:0;position:absolute;z-index:-1"><span for="node-5" class="radio-button-label w-form-label">HER2-<br>HR-</span>
              </label></form>
            <div class="w-form-done">
              <div>Thank you! Your submission has been received!</div>
            </div>
            <div class="w-form-fail">
              <div>Oops! Something went wrong while submitting the form.</div>
            </div>
          </div>
          <div x-data="arrow" x-effect="if (!!value) { show = false }" class="arrow top left small survival">
            <div x-cloak="1" uncloak="1" class="arrow-wrapper">
              <div x-bind="trigger" class="arrow-trigger"></div>
              <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                <div class="arrow-label">Click to view</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div id="therapy" class="section wf-section">
    <div class="sprite-wrapper">
      <div class="container sprite-container w-container">
        <div class="zigzag-sprite-right"></div>
      </div>
    </div>
    <div class="container w-container">
      <div class="section-wrapper">
        <div class="section-content-wrapper center">
          <h2 class="heading">Anti-HER2 therapy</h2>
          <p>A patient’s HER2 status is important for choosing the right treatment. HER2+ breast cancer patients are likely to respond to an anti-HER2 therapy, using a drug called trastuzumab.</p>
          <p>Trastuzumab is a monoclonal antibody that attaches to HER2 present on the cell surface, inhibiting cancer growth.</p>
          <div class="therapy-image-wrapper"><img src="images/Visuals-for-the-IO-mockup_Line-art-12x.png" loading="lazy" width="600" sizes="(max-width: 479px) 87vw, (max-width: 767px) 80vw, 600px" srcset="images/Visuals-for-the-IO-mockup_Line-art-12x-p-500.png 500w, images/Visuals-for-the-IO-mockup_Line-art-12x.png 1200w" alt="HER2+ cell">
            <div class="label text-center">HER2+ cell</div>
            <div x-data="arrow" class="arrow bottom right therapy-1">
              <div x-cloak="1" uncloak="1" class="arrow-wrapper">
                <div x-bind="trigger" class="arrow-trigger"></div>
                <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                  <div class="arrow-label">HER2</div>
                </div>
              </div>
            </div>
            <div x-data="arrow({ delay: 1300 })" class="arrow bottom left therapy-2">
              <div x-cloak="1" uncloak="1" class="arrow-wrapper">
                <div x-bind="trigger" class="arrow-trigger"></div>
                <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                  <div class="arrow-label">Anti-HER2<br>antibody</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div id="history" class="section wf-section">
    <div class="sprite-wrapper">
      <div class="container sprite-container w-container">
        <div class="zigzag-sprite-left"></div>
      </div>
    </div>
    <div class="container w-container">
      <div class="section-wrapper">
        <div class="section-content-wrapper center text-center">
          <h2 class="heading with-subheading">History of trastuzumab</h2>
          <h3 class="label bold">You can explore the history of trastuzumab below</h3>
        </div>
      </div>
    </div>
    <div data-w-id="c9929ef7-2983-9011-b204-c5508ca8e634" class="timeline-wrapper">
      <div class="timeline-sticky">
        <div class="timeline-line"></div>
        <div class="timeline-content">
          <div x-data="arrow({ delay: 100 })" class="arrow bottom left small">
            <div x-cloak="1" uncloak="1" class="arrow-wrapper">
              <div x-bind="trigger" class="arrow-trigger"></div>
              <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                <div class="arrow-label">Scroll to view<br></div>
              </div>
            </div>
          </div>
          <div class="timeline-date">1980</div>
          <div class="timeline-decade">
            <div class="timeline-point _1987">
              <div class="timeline-text">
                <div class="tmeline-hook"></div>
                <div><span class="text-span">1987</span> Research showing that over-expression of HER2 makes tumors more aggressive (Hudziak et al., 1987)</div>
              </div>
            </div>
            <div class="timeline-point _1989">
              <div class="timeline-text">
                <div><span class="text-span">1989</span> Development of an antibody against HER2+ breast tumor cells</div>
                <div class="tmeline-hook"></div>
              </div>
            </div>
          </div>
          <div class="timeline-date">1990</div>
          <div class="timeline-decade">
            <div class="timeline-point _1990">
              <div class="timeline-text">
                <div class="tmeline-hook"></div>
                <div><span class="text-span">1990</span> Development of a humanized version of the anti–HER2 antibody</div>
              </div>
            </div>
            <div class="timeline-point _1992">
              <div class="timeline-text">
                <div><span class="text-span">1992</span> Trastuzumab clinical trials start</div>
                <div class="tmeline-hook"></div>
              </div>
            </div>
            <div class="timeline-point _1998">
              <div class="timeline-text">
                <div class="tmeline-hook"></div>
                <div><span class="text-span">1998</span> FDA approves trastuzumab for women with metastatic HER2+ breast cancer</div>
              </div>
            </div>
          </div>
          <div class="timeline-date">2000</div>
          <div class="timeline-decade"></div>
          <div class="timeline-date">2010</div>
          <div class="timeline-decade">
            <div class="timeline-point _2019">
              <div class="timeline-text">
                <div><span class="text-span">2019</span> FDA grants approval for the first trastuzumab-cytotoxic agentconjugate to treat breast cancer</div>
                <div class="tmeline-hook"></div>
              </div>
            </div>
          </div>
          <div class="timeline-date">2020</div>
        </div>
      </div>
    </div>
  </div>
  <div id="patients" class="section wf-section">
    <div class="gradient-background-wrapper">
      <div class="gradient-highlight">
        <div class="gradient-highlight-half right-top"></div>
        <div class="gradient-highlight-half right-bottom"></div>
      </div>
    </div>
    <div class="sprite-wrapper">
      <div class="w-container">
        <div class="negative-image-wrapper"><img src="images/Visuals-for-the-IO-mockup_Line-art-22x1.png" loading="lazy" sizes="(max-width: 1439px) 100vw, 1200px" width="1200" srcset="images/Visuals-for-the-IO-mockup_Line-art-22x1-p-500.png 500w, images/Visuals-for-the-IO-mockup_Line-art-22x1-p-800.png 800w, images/Visuals-for-the-IO-mockup_Line-art-22x1-p-1080.png 1080w, images/Visuals-for-the-IO-mockup_Line-art-22x1.png 2400w" alt="HER2- cell" class="negative-image">
          <div class="label negative-label">HER2- cell</div>
          <div x-data="arrow" class="arrow top left negative">
            <div x-cloak="1" uncloak="1" class="arrow-wrapper">
              <div x-bind="trigger" class="arrow-trigger"></div>
              <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                <div class="arrow-label">Anti-HER2<br>antibody</div>
              </div>
            </div>
          </div>
          <div x-data="arrow" class="arrow bottom right negative-mobile">
            <div x-cloak="1" uncloak="1" class="arrow-wrapper">
              <div x-bind="trigger" class="arrow-trigger"></div>
              <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                <div class="arrow-label">Anti-HER2<br>antibody</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div class="container w-container">
      <div class="section-wrapper">
        <div class="section-content-wrapper">
          <h2 class="heading">HER2-negative patients</h2>
          <p>As trastuzumab has considerably improved the outcomes in HER2+ breast cancer patients, effort has been made to translate its success into patients that are HER2- or up-regulate HER2 to some degree.</p>
          <div class="negative-image-spacer"></div>
        </div>
      </div>
    </div>
  </div>
  <div id="adc-therapy" class="section wf-section">
    <div class="gradient-background-wrapper">
      <div class="gradient-highlight">
        <div class="gradient-highlight-half top"></div>
        <div class="gradient-highlight-half bottom"></div>
      </div>
    </div>
    <div class="container w-container">
      <div class="section-wrapper">
        <div class="section-columns">
          <div class="section-column left">
            <div class="image-wrapper"><img src="images/Visuals-for-the-IO-mockup_Line-art-32x.png" loading="lazy" width="400" alt="Anti-HER2 antibody-drug conjugate">
              <div class="label text-center">Anti-HER2 ADC<br>(antibody-drug conjugate)</div>
              <div x-data="arrow" class="arrow bottom left anti-therapy-1">
                <div x-cloak="1" uncloak="1" class="arrow-wrapper">
                  <div x-bind="trigger" class="arrow-trigger"></div>
                  <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                    <div class="arrow-label">Anti-HER2<br>antibody</div>
                  </div>
                </div>
              </div>
              <div x-data="arrow({ delay: 1300 })" class="arrow top left anti-therapy-2">
                <div x-cloak="1" uncloak="1" class="arrow-wrapper">
                  <div x-bind="trigger" class="arrow-trigger"></div>
                  <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
                    <div class="arrow-label">Cytotoxic<br>agent</div>
                  </div>
                </div>
              </div>
            </div>
          </div>
          <div class="section-column">
            <div class="section-content-wrapper">
              <h2 class="heading">Anti-HER2 ADC therapy</h2>
              <p>Antibody-Drug Conjugates (ADCs) are a new class of drugs that are created by attaching a cytotoxic or therapeutic agent to an antibody, such as trastuzumab. Trastuzumab linked to a topoisomerase I inhibitor (DXd) is called T-DXd and can be used to target tumors with a variable HER2 expression.</p>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div id="moa" class="section wf-section">
    <div class="sprite-wrapper">
      <div class="container sprite-container w-container">
        <div class="zigzag-sprite-right"></div>
      </div>
    </div>
    <div class="container w-container">
      <div class="section-wrapper">
        <div class="section-content-wrapper center">
          <h2 class="heading">T-DXd mechanism of action</h2>
          <p>T-DXd binds to HER2 present on the surface of a tumor cell. The conjugate is internalized and DXd is released from the anti-HER2 antibody. It enters the nucleus, causing DNA damage and cell death. Finally, T–DXd kills surrounding cancer cells, independently of their HER2 status, through the bystander killing effect.</p>
        </div>
      </div>
    </div>
    <div class="section-wrapper moa-image">
      <div class="moa-image-wrapper">
        <div x-data="arrow" class="arrow bottom right moa-2">
          <div x-cloak="1" uncloak="1" class="arrow-wrapper">
            <div x-bind="trigger" class="arrow-trigger"></div>
            <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
              <div class="arrow-label">HER2</div>
            </div>
          </div>
        </div>
        <div x-data="arrow" class="arrow bottom left moa-2-mobile">
          <div x-cloak="1" uncloak="1" class="arrow-wrapper">
            <div x-bind="trigger" class="arrow-trigger"></div>
            <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
              <div class="arrow-label">HER2</div>
            </div>
          </div>
        </div>
        <div x-data="arrow({ delay: 1300 })" class="arrow bottom left moa-1">
          <div x-cloak="1" uncloak="1" class="arrow-wrapper">
            <div x-bind="trigger" class="arrow-trigger"></div>
            <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
              <div class="arrow-label">Anti-HER2<br>ADC</div>
            </div>
          </div>
        </div>
        <div x-data="arrow({ delay: 2300 })" class="arrow top left moa-3">
          <div x-cloak="1" uncloak="1" class="arrow-wrapper">
            <div x-bind="trigger" class="arrow-trigger"></div>
            <div x-bind="content" class="arrow-content"><img src="images/Arrow-03.png" loading="eager" width="100" alt="Arrow" class="arrow-image"><img src="images/Visuals-for-the-IO-mockup_Arrow-022x.png" loading="eager" width="70" alt="Arrow" class="arrow-image small">
              <div class="arrow-label">Cytotoxic<br>agent</div>
            </div>
          </div>
        </div>
        <div class="moa-image first"><img src="images/1.png" loading="lazy" width="385.5" alt="HER2- cell">
          <div class="label text-center">HER2- cell</div>
        </div>
        <div class="moa-image"><img src="images/2.png" loading="lazy" width="389.5" alt="HER2+ cell">
          <div class="label text-center">HER2+ cell</div>
        </div>
        <div class="moa-image last"><img src="images/3.png" loading="lazy" width="385" alt="HER2- cell">
          <div class="label text-center">HER2- cell</div>
        </div>
      </div>
    </div>
  </div>
  <div id="poll" class="section pop wf-section">
    <div class="container wide w-container">
      <div data-w-id="6b934960-a66e-a047-fde2-9f639a3554ee" style="opacity:0;-webkit-transform:translate3d(0, 0, 0) scale3d(0.8, 0.8, 1) rotateX(0) rotateY(0) rotateZ(0) skew(0, 0);-moz-transform:translate3d(0, 0, 0) scale3d(0.8, 0.8, 1) rotateX(0) rotateY(0) rotateZ(0) skew(0, 0);-ms-transform:translate3d(0, 0, 0) scale3d(0.8, 0.8, 1) rotateX(0) rotateY(0) rotateZ(0) skew(0, 0);transform:translate3d(0, 0, 0) scale3d(0.8, 0.8, 1) rotateX(0) rotateY(0) rotateZ(0) skew(0, 0)" class="poll-wrapper">
        <div class="poll-figure"><img src="images/Visuals-for-the-IO-mockup_Pattern-22x.png" loading="lazy" width="300" alt=""></div>
        <div class="poll-text">
          <h2 class="heading white">Share your opinion!</h2>
          <div x-data="poll" class="poll-content">
            <div class="poll-question">
              <div>
                <p class="bold">Do you think T-DXd has the potential to revolutionize breast cancer treatment in the future?</p>
                <div x-show="!result &amp;&amp; !(loading &amp;&amp; agree === null)" class="poll-buttons">
                  <a x-on:click:prevent:stop="submitPoll(true)" href="#" class="button green w-inline-block"><img src="images/Group-233.svg" loading="eager" x-show="!(loading &amp;&amp; agree === true)" alt="Yes tick" class="button-icon">
                    <div x-cloak="1" x-show="loading &amp;&amp; agree === true" class="poll-button-animation" data-w-id="7b13045f-6ad4-883f-403b-f50b417f0e09" data-animation-type="lottie" data-src="documents/lf30_editor_helrwvhw.json" data-loop="1" data-direction="1" data-autoplay="1" data-is-ix2-target="0" data-renderer="svg" data-default-duration="2.0020019204587935" data-duration="0"></div>
                    <div>Agree</div>
                  </a>
                  <a x-on:click:prevent:stop="submitPoll(false)" href="#" class="button red w-inline-block"><img src="images/Group-133.svg" loading="eager" x-show="!(loading &amp;&amp; agree === false)" alt="No tick" class="button-icon">
                    <div x-cloak="1" x-show="loading &amp;&amp; agree === false" class="poll-button-animation" data-w-id="ba98b7ff-0514-b923-1057-bdb9606ee72b" data-animation-type="lottie" data-src="documents/lf30_editor_axqbwq18.json" data-loop="1" data-direction="1" data-autoplay="1" data-is-ix2-target="0" data-renderer="svg" data-default-duration="2.0020019204587935" data-duration="0"></div>
                    <div>Disagree</div>
                  </a>
                </div>
              </div>
            </div>
            <div x-cloak="1" x-bind:style="{ maxHeight: !!result ? &#x27;300px&#x27; : 0 }" x-show="!!result" x-transition:opacity:200ms="1" class="poll-result">
              <div x-if="!!result" class="poll-results">
                <div>
                  <div>Agree<br></div>
                  <div>Disagree</div>
                </div>
                <div class="poll-result-charts">
                  <div class="poll-result-chart-wrapper">
                    <div x-bind:style="{ width: `${result.yes}%` }" class="poll-result-chart green"></div>
                    <div><span x-text="result.yes">0</span>%</div>
                  </div>
                  <div class="poll-result-chart-wrapper">
                    <div x-bind:style="{ width: `${result.no}%` }" class="poll-result-chart red"></div>
                    <div><span x-text="result.no">0</span>%</div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div id="more-info" class="section wf-section">
    <div id="more-information" class="sprite-wrapper overlap-bottom">
      <div class="more-info-sprite"></div>
    </div>
    <div class="container w-container">
      <div class="section-wrapper more-info">
        <div class="section-content-wrapper">
          <h2 class="heading">More information</h2>
          <p>The ongoing research is laying the foundations for the development of new treatment options for breast cancer patients. Want to learn more about other potential treatments for breast cancer patients with lower levels of HER2 expression? Download <strong>“The Exciting New Field of HER2–Low Breast Cancer Treatment”</strong> by Daniel Eiger et al., 2021.</p>
          <a href="documents/The_Exciting_New_Field_of_HER2-Low_Breast_Cancer_Treatment.pdf" target="_blank" class="download-link w-inline-block">
            <div x-data="{}" x-on:click="conversion(&#x27;paper_download&#x27;)">Download Paper</div>
          </a>
        </div>
      </div>
    </div>
    <div class="container ultrawide w-container">
      <div data-w-id="2b6027e2-6d1d-c3f8-67a5-9082eb779218" style="opacity:0" class="subscription-wrapper">
        <div class="subscription-figure"><img src="images/Visuals-for-the-IO-mockup_Icon2x.png" loading="lazy" width="200" alt=""></div>
        <div class="subscription-content">
          <div class="bold">Would you like us to send you more information about Antibody-Drug Conjugates?</div>
          <div class="subscribe-form-block w-form">
            <form id="wf-form-Newsletter-Form" name="wf-form-Newsletter-Form" data-name="Newsletter Form" method="get" class="subscribe-form-wrapper"><input type="text" class="subscribe-text-field w-input" maxlength="256" name="name" data-name="Name" placeholder="Please enter your email" id="name" required=""><input type="submit" value="Subscribe" data-wait="Please wait..." x-on:click="conversion(&#x27;newsletter_subscribe&#x27;)" x-data="{}" class="button green w-button"></form>
            <div class="success-message w-form-done">
              <div class="success-wrapper">
                <div>Thank you for your interest in our newsletter! Please note that this website is for reference purposes only and the newsletter sign up for this online resource has been temporarily disabled.</div>
              </div>
            </div>
            <div class="error-message w-form-fail">
              <div>Oops! Something went wrong while submitting the form.</div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <footer class="section footer wf-section">
    <div class="container ultrawide w-container">
      <div class="footer-wrapper"><img src="images/TFB-logo2x1.png" loading="lazy" width="59" alt="Tech for Bio logo" class="footer-logo">
        <p>This resource has been developed by <a href="https://www.techforbio.com/" target="_blank">Tech for Bio</a>. If you have any questions, please get in touch with us at <a href="mailto:contact@techforbio.com">contact@techforbio.com</a>. Let us know if you have enjoyed our website! Find us on <a href="https://www.linkedin.com/company/techforbio" target="_blank">LinkedIn</a> and <a href="https://twitter.com/techforbio" target="_blank">Twitter</a>.</p>
        <div class="footer-separator"></div>
        <p class="footer-disclaimer">This website does not provide medical advice. The information, including but not limited to, text, graphics, images and other material contained on this website are for informational and reference purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. The content is not meant to be complete or exhaustive. We also reserve the right to temporarily or permanently discontinue this website or any functionality at any time and without any notice. This website works with third-party services, who help us track and analyze visitor activity.</p>
      </div>
    </div>
  </footer>
  <div x-bind="wrapper" x-cloak="1" x-data="disclaimer" class="disclaimer-wrapper">
    <div class="disclaimer">
      <h2 class="modal-heading">Disclaimer</h2>
      <div class="modal-text">This website does not provide medical advice. The information, including but not limited to, text, graphics, images and other material contained on this website are for reference purposes only. By interacting with our website you consent to the collection, use and sharing of your anonymised activity data to support our digital marketing efforts.</div>
      <a x-bind="button" href="#" class="button green w-inline-block"><img src="images/Group-233.svg" loading="eager" alt="Yes tick" class="button-icon">
        <div>accept</div>
      </a>
    </div>
  </div>
  <div class="custom-code w-embed w-script">
    <script>
const API = 'https://us-central1-sojourer-web.cloudfunctions.net'
document.addEventListener('alpine:init', () => {
{ value: null }
  Alpine.data('survivalPoll', () => ({
    value: null,
    init () {
      this.$watch('value', () => conversion('select_content', { content_type: 'survival_poll' }))
    },
    answer: {
      [`x-transition:leave.opacity.duration.150ms`]: null,
      [`x-transition:enter.opacity.duration.400ms.delay.150ms`]: null
    },
    button: {
      ['@keydown.left']() {
        this.$el.blur()
        return false
      },
      ['@keydown.right']() {
        this.$el.blur()
        return false
      },
      ['@keydown.up']() {
        this.$el.blur()
        return false
      },
      ['@keydown.down']() {
        this.$el.blur()
        return false
      }
    }
  }))
  Alpine.data('arrow', ({ delay } = { delay: 300 }) => ({
    show: false,
    trigger: {
      ['x-intersect.once']() {
        this.show = true
      }
    },
    content: {
      ['x-show']() {
        return this.show
      },
      [`x-transition:enter.duration.600ms`]: null,
      [`x-transition:leave.duration.150ms`]: null,
      [`x-transition:enter.delay.${delay}ms`]: null
    }    
  }))
  Alpine.data('poll', () => ({
    result: null,
    agree: null,
    loading: false,
    async init () {
      const answered = sessionStorage.getItem('txdPoll')
      if (answered) {
        try {
          this.loading = true
          const response = await fetch(`${API}/submitPollTfBWebsite`)
          if (!response.ok) {
            throw new Error(`${response.status}: ${await response.text()}`)
          }
          this.result = await response.json()
        } catch (error) {
          console.error(error)
        } finally {
          this.loading = false
        }
      }
    },
    async submitPoll (agree) {
      if (this.loading) {
        return
      }
      const params = new URLSearchParams({ agree: agree ? 'yes' : 'no' })
      try {
        this.agree = agree
        this.loading = true
        this.result = null
        const response = await fetch(`${API}/submitPollTfBWebsite?${params}`, { method: 'POST' })
        if (!response.ok) {
          throw new Error(`${response.status}: ${await response.text()}`)
        }
        conversion('opinion_poll_submit')
        sessionStorage.setItem('txdPoll', true)
        this.result = await response.json()
      } catch (error) {
        console.error(error)
      } finally {
        this.loading = false
        this.agree = null
      }
    }
  }))
  Alpine.data('disclaimer', () => ({
    show: false,
    init () {
      const accepted = !!(window.localStorage && localStorage.getItem('disclaimer'))
      if (!accepted) {
        this.show = true
      }
    },
    wrapper: {
      ['x-show']() {
        return this.show
      },
      [`x-transition.opacity.duration.400ms`]: null
    },
    button: {
      ['@click']() {
        this.show = false
        // window.scrollTo(0, 0)
        if (window.localStorage) {
          localStorage.setItem('disclaimer', 'accepted')
        }
      }
    }
  }))
})
function conversion(event, params = {}) {
  gtag('event', event, params)
}
/* Open external links in the same tab on mobile devices. */
const mobileQuery = window.matchMedia('screen and (hover: none) and (pointer: coarse)')
if (mobileQuery.matches) {
  document.querySelectorAll('a[target=_blank]').forEach((link) => {
    link.removeAttribute('target')
  })
}
</script>
  </div>
  <script src="https://d3e54v103j8qbb.cloudfront.net/js/jquery-3.5.1.min.dc5e7f18c8.js?site=610e70c5e987d8bd9fc8563b" type="text/javascript" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script>
  <script src="js/ace-demo-io.js" type="text/javascript"></script>
  <!-- [if lte IE 9]><script src="https://cdnjs.cloudflare.com/ajax/libs/placeholders/3.0.2/placeholders.min.js"></script><![endif] -->
</body>
</html>